You have 9 free searches left this month | for more free features.

Immunex, Abgenix, Amgen

Showing 1 - 25 of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Neutropenia Trial in Montevideo (Pegfilgastrim Megalabs, Pegfilgastim Amgen)

Recruiting
  • Neutropenia
  • Pegfilgastrim Megalabs
  • Pegfilgastim Amgen
  • Montevideo, Brazil
    Marcos Giusti
Apr 8, 2022

Colo-rectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

Recruiting
  • Colo-rectal Cancer
  • therascreen® KRAS RGQ PCR Kit
  • Manchester, United Kingdom
    QIAGEN Gaithersburg, Inc
Apr 20, 2022

Melanoma Patients Treated With IMLYGIC® to Characterize Risk of

Recruiting
  • Melanoma
  • Herpetic Infection
    • Jefferson City, Missouri
    • +16 more
    Apr 11, 2022

    Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Trial in

    Completed
    • Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial
    • Information collection
    • Mobile, Alabama
    • +58 more
    Sep 29, 2021

    B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • Tampa, Florida
    • +2 more
    Feb 14, 2022

    Chronic Kidney Disease Trial in Ho Chi Minh City (Stimus)

    Active, not recruiting
    • Chronic Kidney Disease
    • Stimus
    • Ho Chi Minh City, Vietnam
      NANOGEN Pharmaceutical Biotechnology JSC
    Nov 23, 2022

    Gout Attack Trial in New Brunswick (Etanercept, Triamcinolone Acetonide)

    Suspended
    • Gout Attack
    • New Brunswick, New Jersey
      Rutgers, Robert Wood Johnson Medical School, Clinical Research C
    May 10, 2021

    Breast Cancer Trial in Stony Brook (Denosumab)

    Completed
    • Breast Cancer
    • Stony Brook, New York
      Stony Brook University Cancer Center
    Jan 19, 2022

    Anemia, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Ho Chi Minh City (Stimus (NNG-DEPO))

    Active, not recruiting
    • Anemia
    • Chronic Kidney Disease Requiring Chronic Dialysis
    • Stimus (NNG-DEPO)
    • Ho Chi Minh City, Vietnam
      NANOGEN Pharmaceutical Biotechnology JSC
    Jan 4, 2023

    Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

    Completed
    • Advanced Solid Tumors
    • +8 more
    • Modified FOLFOX6
    • +3 more
    • Duarte, California
    • +11 more
    Feb 3, 2021

    Arthroplasty, Replacement, Hip Trial in Los Angeles (Denosumab)

    Withdrawn
    • Arthroplasty, Replacement, Hip
    • Los Angeles, California
      Keck Medicine of USC
    Nov 7, 2020

    Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

    Recruiting
    • Hyperlipidemias
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 18, 2022

    Symptomatic Anemia Trial in Zuidlaren (DA3880, Aranesp)

    Completed
    • Symptomatic Anemia
    • Zuidlaren, Netherlands
      PRA
    Jun 13, 2021

    Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

    Recruiting
    • Infusion Reaction
    • Monoclonal Antibody
    • Montelukast 10 Mg Oral Tablet
    • Clovis, California
      Community Cancer Institute
    Nov 8, 2021

    Cat Allergy, Cat Hypersensitivity Trial in United States (AMG 157, Cat Immunotherapy, Cat Immunotherapy Placebo)

    Completed
    • Cat Allergy
    • Cat Hypersensitivity
    • AMG 157
    • +3 more
    • Los Angeles, California
    • +8 more
    Apr 23, 2020

    Rheumatoid Arthritis Trial (Etanercept)

    Completed
    • Rheumatoid Arthritis
    • (no location specified)
    Jan 17, 2020

    PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life

    Not yet recruiting
    • HER-2 Positive Breast Cancer
    • Efficacy of the Pertuzumab-Trastuzumab combination
    • Clermont-Ferrand, France
    • +5 more
    Nov 20, 2020

    Colorectal Cancer, Metastases Trial (Panitumumab)

    Completed
    • Colorectal Cancer
    • Metastases
    • (no location specified)
    Sep 20, 2018

    Osteoporosis Trial in Tehran (Denosumab, calcium, vitamin D)

    Unknown status
    • Osteoporosis
    • Tehran, Iran, Islamic Republic of
      Rheumatology Center of Iran
    Jul 8, 2020

    Thrombocytopenic Purpura Trial (Romiplostim)

    Completed
    • Thrombocytopenic Purpura
    • (no location specified)
    Dec 5, 2019

    Colorectal Cancer, Metastases Trial (Best supportive care, Panitumumab)

    Completed
    • Colorectal Cancer
    • Metastases
    • (no location specified)
    Jul 9, 2018

    Colorectal Cancer Trial (Oxaliplatin Based Chemotherapy, Panitumumab, Irinotecan Based Chemotherapy)

    Completed
    • Colorectal Cancer
    • Oxaliplatin Based Chemotherapy
    • +3 more
    • (no location specified)
    Sep 20, 2018

    Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers Trial in Ahmedabad (INTP5, US Neulasta)

    Completed
    • Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers
    • INTP5
    • US Neulasta
    • Ahmedabad, Gota, India
      Lambda Therapeutic Research Ltd.
    Sep 13, 2019